Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayako Michino

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10)Makoto Fushimi, Hannes Buck, Melanie Balbach, et al.
Nature Communications|May 23, 2019
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expressionLodoe Lama, Carolina Adura, Wei Xie, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the <i>Mycobacterium tuberculosis</i> ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.
Angewandte Chemie (International Ed. in English)|January 12, 2021
Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized MiceWenhu Zhan, Hao Zhang, John Ginn, et al.
Cancer Discovery|September 2, 2022
Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid LeukemiaYiman Liu, Qinglan Li, Fatemeh Alikarami, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistanceLaura A Kirkman, Wenhu Zhan, Joseph Visone, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10)Makoto Fushimi, Hannes Buck, Melanie Balbach, et al.
Nature Communications|May 23, 2019
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expressionLodoe Lama, Carolina Adura, Wei Xie, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the <i>Mycobacterium tuberculosis</i> ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.
Angewandte Chemie (International Ed. in English)|January 12, 2021
Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized MiceWenhu Zhan, Hao Zhang, John Ginn, et al.
Cancer Discovery|September 2, 2022
Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid LeukemiaYiman Liu, Qinglan Li, Fatemeh Alikarami, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistanceLaura A Kirkman, Wenhu Zhan, Joseph Visone, et al.
Pageof 4